The U.S. Food and Drug Administration (FDA) has issued a voluntary recall of several over-the-counter medications used to treat allergies after discovering that the tablets may have been cross-contaminated with another medication.
The regulator revealed that Unique Pharmaceutical Laboratories recalled cetirizine hydrochloride tablets after discovering they may have been contaminated with ranitidine, a drug previously known as Zantac.
The problem arose when a pharmacy technician saw unusual red dots and discolored cetirizine hydrochloride tablets. Fortunately, no adverse incidents after consumption of the product have been reported so far.
The recall notice explains that some people hypertensive to the ingredients in ranitidine, a drug that can block stomach fluids and is used to treat ulcers and heat burns, may face serious health risks if they consume the cross-contaminated drug.
Possible side effects from taking the affected product can be life-threatening and include low blood pressure, difficulty breathing or swallowing, swelling of the throat and face, itchy skin, hives and even loss of consciousness.
The recall involves bottles of 100 tablets distributed by Rising Pharma Holding Inc. nationwide. Here are the details:
Consumers are advised to contact Rising Pharma Holdings at 1-844-874-7464 during business hours, or by email at [email protected] Or [email protected] to get answers to their questions.
